Study results expected in Fall 2006

MONTREAL, July 10 /PRNewswire/ – BioAxone Therapeutic announced today that it has completed its targeted patient enrollment of the Phase I/IIa North American clinical trial of Cethrin® for the treatment of acute spinal cord injury (SCI). Cethrin®, a recombinant protein-based inhibitor of Rho signaling, is co-delivered with a fibrin sealant and administered once directly onto the surface of the spinal cord during spinal decompression surgery. Results of the trial are expected in the fall of 2006. Continue Reading »

Mac and Jill - Our trip to China

This is an account of our trip to China for Stem Cell Treatment for Jill.   We are using this to help keep family and friends up to date with our progress on this journey.

GREAT BLOG!

SCI-Info-Pages

Resource for those with a spinal cord injury or other disabling injuries or disease of the spine. Provides quadriplegic, paraplegic and caregiver information. This site is a free and informative resource for those suffering from a spinal cord injury or other disabling injuries or diseases of the spine.